Diabetes

Updated 02 February 2017

New diagnostic test for type 1 diabetes

A new test to diagnose type 1 diabetes has been approved by the U.S. Food and Drug Administration.

1

The U.S. Food and Drug Administration has approved a new test that may help doctors diagnose type 1 diabetes, the most common form diagnosed in children and adolescents.

The Kronus ZnT8Ab Elisa Assay may help some people with type 1 diabetes receive faster diagnosis and treatment, the FDA said in a news release. People with type 1 diabetes produce little or no insulin because cells in the pancreas that produce the hormone are mistakenly attacked by the body's immune system.

Insulin is a hormone that converts sugars (glucose) in food to fuel for the body. People who lack the hormone must inject insulin to regulate blood glucose and lower their risk of potential complications, including blindness, kidney failure and heart disease.


Read: New test makes diabetes diagnosis cheaper and faster

The test was able to diagnose a key marker in 65 percent of samples from people diagnosed with type 1 diabetes, and incorrectly gave a positive result in less than 2 percent of samples, the FDA said.

On the other hand, the agency stressed that negative test result should not rule out a diagnosis of type 1 diabetes. The test also shouldn't be used to monitor the body's response to treatment, the FDA added.

The new test is produced by Kronus Market Development Associates, based in Star, Idaho.

Read more:
Discovery may lead to new diabetes treatment
New app alerts doctors when diabetics need help
Artificial pancreas to replace insulin injections


Image: Treating diabetes in a child from Shutterstock

See breaking news and the hottest health tips before anybody else by joining South Africa’s biggest and best health community, like health24 on Facebook now!

 

Read Health24’s Comments Policy

Comment on this story
1 comment
Comments have been closed for this article.

Ask the Expert

Diabetes expert

Dr. May currently works as a fulltime endocrinologist and has been in private practice since 2004. He has a variety of interests, predominantly obesity and diabetes, but also sees patients with osteoporosis, thyroid disorders, men's health disorders, pituitary and adrenal disorders, polycystic ovaries, and disorders of growth. He is a leading member of several obesity and diabetes societies and runs a trial centre for new drugs.

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules